{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T01:31:29Z","timestamp":1785547889048,"version":"3.56.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,12]],"date-time":"2016-10-12T00:00:00Z","timestamp":1476230400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","jacr.org","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Radiology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.jacr.2016.10.003","type":"journal-article","created":{"date-parts":[[2016,12,20]],"date-time":"2016-12-20T23:15:29Z","timestamp":1482275729000},"page":"561-568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Increased Identification of Candidates for High-Risk Breast Cancer Screening Through Expanded Genetic Testing"],"prefix":"10.1016","volume":"14","author":[{"given":"Eric T.","family":"Rosenthal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kidd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystal","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Gorringe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"van Orman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Manley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacr.2016.10.003_bib1","unstructured":"Daly M, Pilarski R, Axilbund JE, et\u00a0al. Genetic\/familial high-risk assessment: breast and ovarian. Version 2.2016. NCCN Clinical Practice Guidelines in Oncology. Available at: http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_screening.pdf."},{"key":"10.1016\/j.jacr.2016.10.003_bib2","unstructured":"Bevers TB, Helvie M, Bonaccio E, et\u00a0al. Breast cancer screening and diagnosis. NCCN Clinical Practice Guidelines in Oncology. Available at: http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast-screening.pdf."},{"key":"10.1016\/j.jacr.2016.10.003_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3322\/canjclin.57.2.75","article-title":"American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography","volume":"57","author":"Saslow","year":"2007","journal-title":"CA Cancer J"},{"key":"10.1016\/j.jacr.2016.10.003_bib4","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1158\/1055-9965.EPI-12-0570","article-title":"Which risk model to use? Clinical implications of the ACS MRI screening guidelines","volume":"22","author":"Ozanne","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jacr.2016.10.003_bib5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/M13-1684","article-title":"Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation","volume":"160","author":"Nelson","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacr.2016.10.003_bib6","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1200\/JCO.2005.03.6772","article-title":"Characterization of BRCA1 and BRCA2 mutations in a large United States sample","volume":"24","author":"Chen","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jacr.2016.10.003_bib7","first-page":"265","article-title":"Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium","volume":"56","author":"Easton","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jacr.2016.10.003_bib8","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium","volume":"62","author":"Ford","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jacr.2016.10.003_bib9","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/jnci\/djt095","article-title":"Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE","volume":"105","author":"Mavaddat","year":"2013","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jacr.2016.10.003_bib10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/jamaoncol.2014.168","article-title":"Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond","volume":"1","author":"Hansford","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jacr.2016.10.003_bib11","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1053\/gast.2001.29611","article-title":"Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families","volume":"121","author":"Pharoah","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacr.2016.10.003_bib12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/jmedgenet-2012-101339","article-title":"High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome","volume":"50","author":"Bubien","year":"2013","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.jacr.2016.10.003_bib13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1897-4287-8-6","article-title":"Cancer and Lhermitte-Duclos disease are common in Cowden syndrome patients","volume":"8","author":"Riegert-Johnson","year":"2010","journal-title":"Hered Cancer Clin Pract"},{"key":"10.1016\/j.jacr.2016.10.003_bib14","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1158\/1078-0432.CCR-11-2283","article-title":"Lifetime cancer risks in individuals with germline PTEN mutations","volume":"18","author":"Tan","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jacr.2016.10.003_bib15","unstructured":"Provenzale D, Gupta S, Ahnen DJ, et\u00a0al. Colorectal cancer screening v. 1.2016. NCCN Clinical Practice Guidelines in Oncology. Available at: http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/colorectal_screening.pdf."},{"key":"10.1016\/j.jacr.2016.10.003_bib16","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1086\/374567","article-title":"Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk","volume":"72","author":"Hwang","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jacr.2016.10.003_bib17","series-title":"GeneReviews\u00ae","year":"1993"},{"key":"10.1016\/j.jacr.2016.10.003_bib18","doi-asserted-by":"crossref","first-page":"5906","DOI":"10.1038\/sj.onc.1209873","article-title":"ATM and breast cancer susceptibility","volume":"25","author":"Ahmed","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.jacr.2016.10.003_bib19","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1056\/NEJM199112263252602","article-title":"Incidence of cancer in 161 families affected by ataxia-telangiectasia","volume":"325","author":"Swift","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacr.2016.10.003_bib20","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/jnci\/dji141","article-title":"Cancer risks and mortality in\u00a0heterozygous ATM mutation carriers","volume":"97","author":"Thompson","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jacr.2016.10.003_bib21","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1086\/421251","article-title":"CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies","volume":"74","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jacr.2016.10.003_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng879","article-title":"Low-penetrance\u00a0susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations","volume":"31","author":"Meijers-Heijboer","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacr.2016.10.003_bib23","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1200\/JCO.2007.12.5922","article-title":"CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls","volume":"26","author":"Weischer","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jacr.2016.10.003_bib24","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1200\/JCO.2012.42.7336","article-title":"CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer","volume":"30","author":"Weischer","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jacr.2016.10.003_bib25","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa1400382","article-title":"Breast-cancer risk in families with mutations in PALB2","volume":"371","author":"Antoniou","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacr.2016.10.003_bib26","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1158\/0008-5472.CAN-10-3958","article-title":"Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer","volume":"71","author":"Casadei","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.jacr.2016.10.003_bib27","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nature05609","article-title":"A\u00a0recurrent mutation in PALB2 in Finnish cancer families","volume":"446","author":"Erkko","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jacr.2016.10.003_bib28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/ng1959","article-title":"PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene","volume":"39","author":"Rahman","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacr.2016.10.003_bib29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12885-015-1224-y","article-title":"Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk","volume":"15","author":"Judkins","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jacr.2016.10.003_bib30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/cge.12315","article-title":"A\u00a0comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes","volume":"86","author":"Eggington","year":"2014","journal-title":"Clin Genet"},{"key":"10.1016\/j.jacr.2016.10.003_bib31","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the\u00a0interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"15_suppl","key":"10.1016\/j.jacr.2016.10.003_bib32","first-page":"1580","article-title":"Detection of somatic variants in peripheral blood lymphocytes using a\u00a025-gene hereditary cancer panel","volume":"34","author":"Coffee","year":"2016","journal-title":"ASCO Meeting Abstr"},{"key":"10.1016\/j.jacr.2016.10.003_bib33","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5","article-title":"Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction","volume":"73","author":"Claus","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.jacr.2016.10.003_bib34","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/ejhg.2014.16","article-title":"Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes","volume":"22","author":"Castera","year":"2014","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jacr.2016.10.003_bib35","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1245\/s10434-015-4754-2","article-title":"Multigene panel testing detects equal rates of pathogenic BRCA1\/2 mutations and has a higher diagnostic yield compared to limited BRCA1\/2 analysis alone in patients at risk for hereditary breast cancer","volume":"22","author":"Kapoor","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jacr.2016.10.003_bib36","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jamaoncol.2015.2690","article-title":"Clinical actionability of multigene panel testing for hereditary breast and ovarian cancer risk assessment","volume":"1","author":"Desmond","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jacr.2016.10.003_bib37","doi-asserted-by":"crossref","first-page":"14205","DOI":"10.1073\/pnas.1415979111","article-title":"Population-based\u00a0screening for breast and ovarian cancer risk due to BRCA1\u00a0and\u00a0BRCA2","volume":"111","author":"Gabai-Kapara","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacr.2016.10.003_bib38","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1200\/JCO.2014.57.1414","article-title":"Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer","volume":"33","author":"Couch","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jacr.2016.10.003_bib39","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/sim.1668","article-title":"A\u00a0breast cancer prediction model incorporating familial and personal risk factors","volume":"23","author":"Tyrer","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.jacr.2016.10.003_bib40","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/gutjnl-2012-303108","article-title":"International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer","volume":"62","author":"Canto","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.jacr.2016.10.003_bib41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1158\/2159-8290.CD-11-0194","article-title":"ATM mutations in patients with hereditary pancreatic cancer","volume":"2","author":"Roberts","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jacr.2016.10.003_bib42","unstructured":"Ajani J, D\u2019Amico T, Almhanna K, et\u00a0al. NCCN Clinical Practice Guidelines in Oncology\u00ae: gastric cancer. V 1.2016. NCCN Clinical Practice Guidelines in Oncology. Available at: https:\/\/www.nccn.org\/store\/login\/login.aspx?ReturnURL=https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/gastric.pdf."}],"container-title":["Journal of the American College of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1546144016310328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1546144016310328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T18:53:36Z","timestamp":1536173616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1546144016310328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1546144016310328"],"URL":"https:\/\/doi.org\/10.1016\/j.jacr.2016.10.003","relation":{},"ISSN":["1546-1440"],"issn-type":[{"value":"1546-1440","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased Identification of Candidates for High-Risk Breast Cancer Screening Through Expanded Genetic Testing","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacr.2016.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American College of Radiology.","name":"copyright","label":"Copyright"}]}}